Toggle Nav
Close
  • Menu
  • Setting

Anti-IL-5Ra/ CD125 Antibody (Benralizumab)

Catalog No.
F1214
Anti-IL-5Ra/ CD125 Antibody (Benralizumab)
Grouped product items
SizePriceStock Qty
100ug
$135.00
Ship with 3-5 days
1mg
$405.00
Ship with 3-5 days
5mg
$1,053.00
Ship with 3-5 days
50mg
$3,538.00
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Benralizumab (MEDI-563) is an interleukin 5 receptor alpha (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils by enhancing antibody-dependent cell-mediated cytotoxicity. All. Benralizumab is indicated for severe eosinophilic asthma.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

146.06 kDa

Shipping

Dry ice

Cas No.

1044511-01-4

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

Fasenra, MEDI-563, BIW-8405

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

Q01344

Reactivity

Human, Mouse, Rat

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

Immobilized human IL 5Rα His at 2 ug/mL can bind Anti-IL-5Ra/ CD125 Antibody (Benralizumab)

Target

IL-5Ra/ CD125

Note

Please avoid freeze-thaw cycles.